We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Method Preserves Microfluidic Devices for HIV Monitoring in Developing Countries

By LabMedica International staff writers
Posted on 03 May 2016
Print article
Microfluidic devices with immunochemistry have broad applications in chemotherapy monitoring, transplant patient monitoring, and especially in monitoring the efficacy of antiretroviral therapy.

Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art medical equipment poses a number of challenges. A novel method has been developed to store microfluidic devices for CD4 T cell testing in extreme weather conditions for up to six months without refrigeration.

Bioengineers at Stanford University School of Medicine (Palo Alto, CA, USA) and their colleagues employed a lensless imaging method to rapidly count CD4 T cells using complementary metal-oxide semiconductor (CMOS) sensor, the same imaging sensor found in cell phone cameras. Lensless imaging technology allows rapid cell counting and does not require skilled technicians to operate, making it suitable for point-of-care settings. If produced at a large scale, the microfluidic device would cost less than USD 1 compared with the current cost of a CD4 assay, which is about USD 30–50.

The investigators used trehalose, a form of sugar that is present in some plants and animals, to preserve the microfluidic device. Since trehalose has the capability to enable plants to thrive in very harsh hot and cold conditions, they determined that it could have the same effect on multilayer surfaces like a microfluidic device. They packaged and vacuum-sealed the trehalose treated device in plastic and used a drying agent to address the effects of humidity. They exposed the device to extreme weather conditions in a laboratory environment to test its functionality and shelf life.

The results of the study revealed that they were able to preserve the microfluidic devices over a period of six months using this method. At room temperature, they observed 90% specificity for up to six months. The engineers also integrated these stabilized microfluidic devices post-reactivation with the CMOS lensless imaging technology. The captured CD4 T cells were counted rapidly and automatically from unprocessed whole blood, creating a portable, battery-operated, inexpensive, and microscope-free CD4 T cell counting platform with a long shelf life.

Waseem Asghar, PhD, an assistant professor of electrical engineering and co-first author of the study, said, “Monitoring HIV patients at point-of-care settings in resource-constrained countries like Africa are critical in knowing how their treatment is progressing and whether or not a particular drug is working the way it should.” The study was originally published online on February 17, 2016, in the journal Scientific Reports.

Related Links:
Stanford University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.